Literature DB >> 19032963

N-acetylaspartate (NAA) correlates inversely with cannabis use in a frontal language processing region of neocortex in MDMA (Ecstasy) polydrug users: a 3 T magnetic resonance spectroscopy study.

Ronald L Cowan1, James M Joers, Mary S Dietrich.   

Abstract

Impaired verbal memory is common in MDMA (Ecstasy) polydrug users. The contributions of Ecstasy or polydrug exposure to reduced verbal memory are unclear, as is the neural basis for this cognitive deficit. Ecstasy users have reduced gray matter in brain regions mediating verbal memory (BA 18, 21 and 45). N-acetylaspartate (NAA) as a neuronal marker and myoinositol (mI) as a glial marker are inconsistently affected in Ecstasy users. We used 3 T MRS in 17 recreational drug users to test the hypothesis that Ecstasy polydrug use would be associated with altered NAA or mI in BA 18, 21 and 45. No effects were seen for mI. Metabolite ratios for NAA (mean+/-SD) were: BA 18-NAA/Cr (2.030+/-0.188); BA 21-NAA/Cr (1.861+/-0.325); BA 45-NAA/Cr (1.925+/-0.329). Lifetime cannabis use was significantly associated with BA 45 NAA/Cr (r=-0.687, p=0.014) but not with NAA in BA 18 or 21. In contrast, there were no statistically significant associations for lifetime use of Ecstasy, alcohol, or cocaine with NAA. These findings suggest that cannabis use may contribute to altered neuronal integrity in Ecstasy polydrug users in a brain region associated with verbal memory processing.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19032963      PMCID: PMC4451227          DOI: 10.1016/j.pbb.2008.10.022

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  50 in total

Review 1.  MDMA use and neurocognition: a meta-analytic review.

Authors:  Ari D Kalechstein; Richard De La Garza; James J Mahoney; William E Fantegrossi; Thomas F Newton
Journal:  Psychopharmacology (Berl)       Date:  2006-11-03       Impact factor: 4.530

2.  Quantitative PET studies of the serotonin transporter in MDMA users and controls using [11C]McN5652 and [11C]DASB.

Authors:  Una D McCann; Zsolt Szabo; Esen Seckin; Peter Rosenblatt; William B Mathews; Hayden T Ravert; Robert F Dannals; George A Ricaurte
Journal:  Neuropsychopharmacology       Date:  2005-09       Impact factor: 7.853

Review 3.  Biological and clinical MRS at ultra-high field.

Authors:  H P Hetherington; J W Pan; W J Chu; G F Mason; B R Newcomer
Journal:  NMR Biomed       Date:  1997-12       Impact factor: 4.044

4.  Ecstasy induces apoptosis via 5-HT(2A)-receptor stimulation in cortical neurons.

Authors:  João Paulo Capela; Eduarda Fernandes; Fernando Remião; Maria Lourdes Bastos; Andreas Meisel; Félix Carvalho
Journal:  Neurotoxicology       Date:  2007-04-27       Impact factor: 4.294

5.  A prospective cohort study on sustained effects of low-dose ecstasy use on the brain in new ecstasy users.

Authors:  Maartje M L de Win; Liesbeth Reneman; Gerry Jager; Erik-Jan P Vlieger; Sílvia D Olabarriaga; Cristina Lavini; Ivo Bisschops; Charles B L M Majoie; Jan Booij; Gerard J den Heeten; Wim van den Brink
Journal:  Neuropsychopharmacology       Date:  2006-11-01       Impact factor: 7.853

6.  Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings.

Authors:  U D McCann; Z Szabo; U Scheffel; R F Dannals; G A Ricaurte
Journal:  Lancet       Date:  1998-10-31       Impact factor: 79.321

7.  Patterns of ecstasy use in Australia: findings from a national household survey.

Authors:  Louisa Degenhardt; Bridget Barker; Libby Topp
Journal:  Addiction       Date:  2004-02       Impact factor: 6.526

8.  Ecstasy and drug consumption patterns: a Canadian rave population study.

Authors:  Samantha R Gross; Sean P Barrett; John S Shestowsky; Robert O Pihl
Journal:  Can J Psychiatry       Date:  2002-08       Impact factor: 4.356

9.  Reduced cortical gray matter density in human MDMA (Ecstasy) users: a voxel-based morphometry study.

Authors:  Ronald L Cowan; In Kyoon Lyoo; Seung Mo Sung; Kyung Heup Ahn; Minue J Kim; Jaeuk Hwang; Erika Haga; Ram Lakhan Panday Vimal; Scott E Lukas; Perry F Renshaw
Journal:  Drug Alcohol Depend       Date:  2003-12-11       Impact factor: 4.492

10.  Cognition in novice ecstasy users with minimal exposure to other drugs: a prospective cohort study.

Authors:  Thelma Schilt; Maartje M L de Win; Maarten Koeter; Gerry Jager; Dirk J Korf; Wim van den Brink; Ben Schmand
Journal:  Arch Gen Psychiatry       Date:  2007-06
View more
  17 in total

1.  Correlates of African American female adolescent offenders 3, 4-Methylenedioxymethamphetamine (MDMA or "Ecstasy") use and sexually transmitted infection morbidity.

Authors:  Torrance Stephens; Rhonda Conerly Holliday; Shakita Hopkins; Shanhol Rose; Ronald Braithwaite; Selina Smith
Journal:  J Hum Behav Soc Environ       Date:  2015-09-29

Review 2.  Neurochemistry of drug action: insights from proton magnetic resonance spectroscopic imaging and their relevance to addiction.

Authors:  Stephanie C Licata; Perry F Renshaw
Journal:  Ann N Y Acad Sci       Date:  2010-02       Impact factor: 5.691

3.  Effect of cocaine on structural changes in brain: MRI volumetry using tensor-based morphometry.

Authors:  Ponnada A Narayana; Sushmita Datta; Guozhi Tao; Joel L Steinberg; F Gerard Moeller
Journal:  Drug Alcohol Depend       Date:  2010-05-31       Impact factor: 4.492

4.  MDMA administration decreases serotonin but not N-acetylaspartate in the rat brain.

Authors:  Shane A Perrine; Farhad Ghoddoussi; Mark S Michaels; Elisabeth M Hyde; Donald M Kuhn; Matthew P Galloway
Journal:  Neurotoxicology       Date:  2010-08-26       Impact factor: 4.294

5.  Human ecstasy (MDMA) polydrug users have altered brain activation during semantic processing.

Authors:  Tristan J Watkins; Vidya Raj; Junghee Lee; Mary S Dietrich; Aize Cao; Jennifer U Blackford; Ronald M Salomon; Sohee Park; Margaret M Benningfield; Christina R Di Iorio; Ronald L Cowan
Journal:  Psychopharmacology (Berl)       Date:  2012-12-16       Impact factor: 4.530

6.  Factors associated with initiation of ecstasy use among US adolescents: findings from a national survey.

Authors:  Ping Wu; Xinhua Liu; Bin Fan
Journal:  Drug Alcohol Depend       Date:  2009-09-24       Impact factor: 4.492

7.  Self-reported ecstasy (MDMA) use and past occurrence of sexually transmitted infections (STIs) in a cohort juvenile detainees in the USA.

Authors:  Torrance Stephens; Rhonda Conerly Holliday; Jerriyauna Jarboe
Journal:  J Community Health       Date:  2015-04

8.  Decreased frontal N-acetylaspartate levels in adolescents concurrently using both methamphetamine and marijuana.

Authors:  Young-Hoon Sung; Paul D Carey; Dan J Stein; Helen L Ferrett; Bruce S Spottiswoode; Perry F Renshaw; Deborah A Yurgelun-Todd
Journal:  Behav Brain Res       Date:  2013-03-04       Impact factor: 3.332

9.  Glutamate, N-acetyl aspartate and psychotic symptoms in chronic ketamine users.

Authors:  James M Stone; Fiona Pepper; Johnson Fam; Hannah Furby; Emer Hughes; Celia Morgan; Oliver D Howes
Journal:  Psychopharmacology (Berl)       Date:  2013-11-22       Impact factor: 4.530

Review 10.  Structural and functional imaging studies in chronic cannabis users: a systematic review of adolescent and adult findings.

Authors:  Albert Batalla; Sagnik Bhattacharyya; Murat Yücel; Paolo Fusar-Poli; Jose Alexandre Crippa; Santiago Nogué; Marta Torrens; Jesús Pujol; Magí Farré; Rocio Martin-Santos
Journal:  PLoS One       Date:  2013-02-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.